Aliko Scientific Wins Major Tender at Federico II University Hospital
Aliko Scientific SA, through its subsidiary Hospitex International S.r.l., has secured a major five-year public tender from the Azienda Ospedaliera Universitaria Federico II. This tender involves supplying a diagnostic system and liquid-based cytology reagents for the Department of Onco-Hematology’s Cytopathology and Predictive Molecular Pathology program.
PARIS–(BUSINESS WIRE)–Regulatory News: Aliko Scientific SA (former Ikonisys SA) (Euronext Growth Paris: ALIKO) – today announces that its fully own subsidiary Hospitex International S.r.l. has been awarded a significant five-year public tender issued by the Azienda Ospedaliera Universitaria Federico II for the supply of a diagnostic system and liquid-based cytology reagents for the Intradepartmental Program of Cytopathology and Predictive Molecular Pathology within the Department of Onco-Hema